Tag: Bioxyne
Bioxyne signs $5.6M supply agreement to enter German medical cannabis market
Bioxyne Limited), through its subsidiary Breathe Life Sciences (BLS), has entered the German medical cannabis market by securing a commercial supply agreement worth a minimum of €3.2 million (approximately AUD 5.6 million) for FY2026.
Bioxyne granted Australia’s first GMP licence for Psilocybin and MDMA manufacturing
Bioxyne Limited's subsidiary, Breathe Life Sciences (BLS), has secured the Good Manufacturing Practice (GMP) licence for the production of medical cannabis.
Featured Article
Behind the Australian Made logo: Six manufacturers shaping local industry
Australian manufacturers are continuing to invest in local production, innovation and sustainability across a wide range of industries. From textiles and packaging to construction and advanced manufacturing, Australian Made licensees are developing products tailored to local conditions while supporting Australian jobs and capabilities.
